Skip to main content
Log in

Dual-Isotope Imaging of Neutron-Activated Erbium-171 and Samarium-153 and the in Vivo Evaluation of a Dual-Labeled Bilayer Tablet by Gamma Scintigraphy

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. D. L. Casey, R. M. Beihn, G. A. Digenis, and M. D. Shambu. Method for monitoring hard gelatin capsule disintegration times in human using external scintigraphy. J. Pharm. Sci. 65:1412–1413 (1976).

    Google Scholar 

  2. G. A. Digenis. The utilization of short-lived radionuclides in the assessment of formulation and in vivo disposition of drugs. In C. G. Wilson and J. G. Hardy (eds.), Radionuclide Imaging in Drug Research, Croom Helm, London, 1982, p. 103.

    Google Scholar 

  3. C. G. Wilson, G. D. Parr, J. W. Kennerley, M. J. Taylor, J. G. Hardy, and J. Rees. Pharmacokinetics and in vivo scintigraphic monitoring of a sustained release acetylsalicylic acid formulation. Int. J. Pharm. 18:1–8 (1984).

    Google Scholar 

  4. A. F. Parr, R. M. Beihn, G. J. Szpunar, and M. Jay. Correlation of ibuprofen bioavailability with gastrointestinal transit by scintigraphic monitoring of Er-171 labelled sustained release tablets. Pharm. Res. 4:486–489 (1987).

    Google Scholar 

  5. J. G. Hardy, D. F. Evans, I. Zaki, A. G. Clark, H. H. Tonneson, and O. N. Gamst. Evaluation of an enteric coated naproxen tablet using gamma scintigraphy and pH monitoring. Int. J. Pharm. 37:245–250 (1987).

    Google Scholar 

  6. C. G. Wilson, N. Washington, J. G. Hardy, and S. W. Bond. The influence of food on the absorption of acyclovir: A pharmacokinetic and scintigraphic assessment. Int. J. Pharm. 38:221–225 (1987).

    Google Scholar 

  7. J. G. Hardy, J. N. C. Healey, and J. R. Reynolds. Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 1:273–280 (1987).

    Google Scholar 

  8. C. G. Wilson, N. Washington, J. L. Greaves, F. Kamali, J. A. Rees, A. K. Sempik, and J. F. Lampard. Bimodal release of ibuprofen in a sustained-release formulation: A scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake. Int. J. Pharm. 50:155–161 (1989).

    Google Scholar 

  9. L. C. Feely and S. S. Davis. Correlation of phenylpropanolamine bioavailability with gastrointestinal transit by scintigraphic monitoring of In-111 labelled hydroxypropylmethylcellulose matrices. Pharm. Res. 6:274–278 (1989).

    Google Scholar 

  10. G. Graffner, Z. Wagner, M. Nilsson, and E. Widerlov. Plasma concentrations of remoxipride and the gastrointestinal transit of In-lll marked extended-release coated spheres. Pharm. Res. 7:54–58 (1990).

    Google Scholar 

  11. M. T. Borin, S. Khare, R. M. Beihn, and M. Jay. The effect food on gastrointestinal transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy. Pharm. Res. 7:304–307 (1990).

    Google Scholar 

  12. G. A. Digenis, E. P. Sandefer, R. M. Beihn, A. F. Parr, C. McClain, I. Ghebre-Sellasssie, U. Iyer, R. U. Nesbitt, B. M. Scheinthal, and E. Randinitis. Gastrointestinal behavior of orally-administered erythromycin pellets in man as determined by gamma scintigraphy. J. Clin. Pharmacol. 30:621–631 (1990).

    Google Scholar 

  13. A. F. Parr, M. Jay, G. A. Digenis, and R. M. Beihn. Radiolabelling of intact tablets by neutron activation for in vivo scintigraphic studies. J. Pharm. Sci. 74:590–591 (1985).

    Google Scholar 

  14. A. F. Parr, R. M. Beihn, and M. Jay. Radiolabelling of an enteric coated tablet by (n,γ) radioactivation of erbium-170 for scintigraphic imaging. Int. J. Pharm. 32:251–256 (1986).

    Google Scholar 

  15. A. F. Parr and M. Jay. Radiolabelling of intact dosage forms by neutron activation: Effects on in vitro performance. Pharm.Res. 4:526–528 (1987).

    Google Scholar 

  16. A. F. Parr, G. A. Digenis, E. P. Sandefer, I. Ghebre-Sellasssie, U. Iyer, R. U. Nesbitt, and B. M. Scheinthal. Manufacture and properties of erythromycin beads containing neutron-activated erbium-171. Pharm. Res. 7:264–269 (1990).

    Google Scholar 

  17. S. Z. Masih, N. Clipse, and C. Fleenor. Preparation of clinical samples of solid dosage forms for radioscintigraphic studies in humans without radioactive contamination of laboratory and production equipment. Pharm. Res. 6:S-76 (1989).

    Google Scholar 

  18. S. Z. Masih, E. Sandefer, G. A. Digenis, R. M. Beihn, T. S. Foster, N. M. Clipse, C. Fleenor, S. H. Wu, and J. C. Gilmer. Evaluation of cellulose acetate trimellitate as a new enteric polymer by scintigraphic technique and its effect on the pharmacokinetics of 5-ASA. Pharm. Res. 6:-137 (1989).

    Google Scholar 

  19. M. D. Glascock. Tables for Neutron Activation Analysis, 2nd ed., University of Missouri Press, Columbia, 1988.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Digenis, G.A., Sandefer, E.P., Beihn, R.M. et al. Dual-Isotope Imaging of Neutron-Activated Erbium-171 and Samarium-153 and the in Vivo Evaluation of a Dual-Labeled Bilayer Tablet by Gamma Scintigraphy. Pharm Res 8, 1335–1340 (1991). https://doi.org/10.1023/A:1015876401639

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015876401639

Navigation